Title

Detection of familial hypercholesterolaemia: a major treatment gap in preventative cardiology

RIS ID

107265

Publication Details

Bates, T. R., Burnett, J. R., van Bockxmeer, F. M., Hamilton, S., Arnolda, L. & Watts, G. F. (2008). Detection of familial hypercholesterolaemia: a major treatment gap in preventative cardiology. Heart Lung and Circulation, 17 (5), 411-413.

Abstract

Familial hypercholesterolaemia (FH) is a common genetic disorder that untreated has an almost one hundredfold risk of coronary artery disease (CAD). In an audit of 334 patients with premature CAD admitted to a Department of Cardiology, only 60% of medical records had sufficient clinical information for identifying FH. Of those with sufficient information recorded, 54% of patients had possible to definite FH on recognised clinical criteria. Amongst those with FH, only 38% were on statin therapy and only 22% were treated to National Heart Foundation targets. Detection and treatment of FH represents a major gap in coronary prevention.

Please refer to publisher version or contact your library.

Share

COinS
 

Link to publisher version (DOI)

http://dx.doi.org/10.1016/j.hlc.2007.06.005